Drug recall · January 22, 2020
Sumatriptan Succinate Tablets recall
Why: Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ
- Lots / codes
a) JKU1939A, JKU1940A, JKU1940B, exp. date 04/2022 and b) JKT4175A, exp. date 11/2020
- Quantity
- 384/100 count bottles
- Company
- Sun Pharmaceutical Industries, Inc., Cranbury, NJ
- Distribution
- Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.
- Initiated
- December 26, 2019 · Voluntary: Firm initiated
- Classified
- January 13, 2020
- Reported
- January 22, 2020
- Ended
- October 22, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sumatriptan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.